
University of Washington-based research institute.
The Institute for Protein Design (IPD) was founded at the University of Washington with a core mission to create new proteins that address modern scientific and medical challenges. The institute focuses on pioneering research in protein design, offering services and tools that facilitate the development of novel proteins for therapeutic and industrial applications. Their market focus includes healthcare, biotechnology, and environmental sectors, aiming to revolutionize treatments and solutions through advanced protein engineering.
Notable affiliated individuals include David Baker, a prominent figure in the field of computational biology and protein design. The institute has garnered significant achievements, such as breakthroughs in COVID-19 therapeutics and innovative software tools for protein modeling. Supported by a robust advisory board and collaborations with leading researchers, IPD has made a substantial impact on scientific research and practical applications, positioning itself as a leader in the protein design landscape.

Scripps Research Institute
scripps.edu

Profluent Bio
profluent.bio

AI Proteins
aiproteinstx.com

UW Create
create.uw.edu

Cyrus Biotechnology
cyrusbio.com

Institute for Systems Biology
isbscience.org

Diffuse Bio
diffuse.bio

Inceptive
inceptive.life

Ibbr

Integrated Protein Technologies
iptinc.com

Protein Foundry
proteinfoundry.com

Protillion Biosciences
protillion.com

RevivBio
revivbio.com

Nabla Bio
nabla.bio

Redesign Science
Companies similar to Institute for Protein Design include Scripps Research Institute, Profluent Bio, AI Proteins and UW Create.
Institute for Protein Design was founded in 2012.
Institute for Protein Design's headquarters is located in Seattle, WA, US.
Institute for Protein Design's most recent funding round was for $45M (USD) in April 2019.
As of Apr 16, 2019, Institute for Protein Design has raised a total of $56.3M (USD).
Institute for Protein Design has 175 employees as of Feb 4, 2024.